Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome

Published:2023-04-21 Issue:2 Volume:3 Page:109-113
ISSN:2673-6179
Container-title:Dermato
language:en
Short-container-title:Dermato

Author:

Rodenas-Herranz Teresa¹²,Cebolla-Verdugo Marta¹³,Llamas-Segura Carlos¹,Ruiz-Villaverde Ricardo¹²^ORCID,Herranz-Marín Maria Teresa¹³

Affiliation:

1. Hospital Universitario San Cecilio, 18016 Granada, Spain

2. Instituto Biosanitario de Granada—Ibs, 18016 Granada, Spain

3. Hospital Universitario Morales Messeguer, 30008 Murcia, Spain

Abstract

Dear Editor: Alopecia areata (AA) is a form of alopecia whose prevalence ranges from 0 [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2673-6179/3/2/9/pdf

Reference17 articles.

1. Janus Kinase Inhibitors in the Treatment of Alopecia Areata;Stefanis;Prague Med. Rep.,2023

2. Efficacy of low-dose of baricitinib in the treatment of patchy alopecia and sicca syndrome in an SLE patient;Chen;Scand J. Rheumatol.,2022

3. Role of janus kinase inhibitors in the treatment of alopecia areata;Triyangkulsri;Drug Des. Devel. Ther.,2018

4. Kwon, O., Senna, M.M., Sinclair, R., Ito, T., Dutronc, Y., Lin, C.Y., Yu, G., Chiasserini, C., McCollam, J., and Wu, W.S. (2023). Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2). Am. J. Clin. Dermatol., 1–9.

5. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata;Dai;JCI Insight,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP